Skip to main content
SpringerLink
Log in
Book cover

Antidepressants: Past, Present and Future

  • Book
  • © 2004

Overview

Editors:
  1. Sheldon H. Preskorn

    1. Department of Psychiatry and Behavioral Sciences, University of Kansas School of Medicine and Psychiatric Research Insitute, 1010 N. Kansas, Wichita, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. John P. Feighner

    1. Feighner Research Institute, San Diego, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Christina Y. Stanga

    1. Neillsville, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  4. Ruth Ross

    1. Ross Editorial, Independence, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 157)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 509.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 649.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 649.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (20 chapters)

  1. Front Matter

    Pages I-XII
    Download chapter PDF

  2. Basic Principles: Pharmacologic Science

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. Biochemical and Physiological Processes in Brain Function and Drug Actions

      • W. D. Horst
      Pages 3-33

    3. General Principles of Pharmacokinetics

      • S. H. Preskorn, M. L. Catterson
      Pages 35-86

    4. Therapeutic Drug Monitoring of Antidepressants

      • M. J. Burke, S. H. Preskorn
      Pages 87-114

  3. Basic Principles: Clinical Science

    1. Front Matter

      Pages 115-115
      Download chapter PDF

    2. Biological Markers of Depression

      • T. J. Connor, B. E. Leonard
      Pages 117-148

    3. Quality of Life and Rating Scales of Depression

      • P. Bech
      Pages 149-167

  4. Current Pharmacotherapy of Major Depressive Disorder

    1. Front Matter

      Pages 169-169
      Download chapter PDF

    2. Overview of Currently Available Antidepressants

      • S. H. Preskorn, R. Ross
      Pages 171-183

    3. Tricyclic Antidepressants

      • M. Lader
      Pages 185-208

    4. Monoamine Oxidase Inhibitors

      • S. H. Kennedy, A. Holt, G. B. Baker
      Pages 209-239

    5. Selective Serotonin Reuptake Inhibitors

      • S. H. Preskorn, R. Ross, C. Y. Stanga
      Pages 241-262

    6. Other Antidepressants

      • S. H. Preskorn, R. Ross
      Pages 263-324

    7. Current Role of Herbal Preparations

      • D. Wheatley
      Pages 325-351

  5. Use of Antidepressants in Special Populations

    1. Front Matter

      Pages 353-353
      Download chapter PDF

    2. Children and Adolescents

      • J. F. Bober, S. H. Preskorn
      Pages 355-378

    3. Women

      • K. A. Yonkers, O. Brawman-Mintzer
      Pages 379-392

    4. Older Adults

      • S. Glover, W. F. Boyer
      Pages 393-420

    5. Bipolar Mood Disorders

      • R. D. Alarcon
      Pages 421-446
Back to top

Keywords

About this book

This book is being published as we mark the end of the first 50 years of the modern antidepressant era. This era began with the chance discovery that tri- clic antidepressants and monoamine oxidase inhibitors had antidepressant p- perties. That discovery had three consequences. First, it brought simple and effective treatment to patients suffering from major depressive illnesses. Second, these discoveries, together with the discovery of lithium and chlorpromazine, began the remedicalization of psychiatry by making it clear that the treatment of many of the major psychiatric illnesses can be approached in the same way as other medical conditions. However, the most far-reaching effect was to provide the first clue as to what mechanisms might underlie antidepressant efficacy, a development that has led to an explosion in the number of available an- depressants and to their widespread use. The goal of this book is to provide a thorough review of the current status of antidepressants—how we arrived at this point in their evolution and where we are going in both the near and the long term. The book employs both a scientific and historical approach to accomplish these goals. The book is intended for practitioners who use antidepressants on a daily basis in their practice as well as for the student and researcher. Each will find that the book provides a comprehensive and logical approach to this important group of medications. The importance of the book is a function of its topic.

Editors and Affiliations

  • Department of Psychiatry and Behavioral Sciences, University of Kansas School of Medicine and Psychiatric Research Insitute, 1010 N. Kansas, Wichita, USA

    Sheldon H. Preskorn

  • Feighner Research Institute, San Diego, USA

    John P. Feighner

  • Neillsville, USA

    Christina Y. Stanga

  • Ross Editorial, Independence, USA

    Ruth Ross

Bibliographic Information

  • Book Title: Antidepressants: Past, Present and Future

  • Editors: Sheldon H. Preskorn, John P. Feighner, Christina Y. Stanga, Ruth Ross

  • Series Title: Handbook of Experimental Pharmacology

  • DOI: https://doi.org/10.1007/978-3-642-18500-7

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin Heidelberg 2004

  • Hardcover ISBN: 978-3-540-43054-4Published: 19 February 2004

  • Softcover ISBN: 978-3-642-62135-2Published: 10 October 2012

  • eBook ISBN: 978-3-642-18500-7Published: 06 December 2012

  • Series ISSN: 0171-2004

  • Series E-ISSN: 1865-0325

  • Edition Number: 1

  • Number of Pages: XII, 615

  • Topics: Pharmacology/Toxicology, Neurology, Neurosciences

Publish with us

Policies and ethics

Back to top

Search

Navigation